|
|
 The National High Field Nuclear Magnetic Resonance Centre, NANUC, was created in 1999 to serve the needs of the Canadian NMR community with public access to the highest commercially available NMR field at that time (800 MHz). Since its inception NANUC has provided the International NMR community with scientific and technical excellence to over 100 principle investigators from 40 institutions worldwide. Over the past 9 years NANUC has had every aspect of its operation and design copied by institutions and facilities around the globe.
Recently, NANUC has built upon its reputation of excellence to provide formal NMR education programs offering specialized NMR training by the leading international experts in the topic areas. The NMR BootCamp™ band is now in its 3rd year and is moving to an international arena with the 2008 BootCamp being offered, by invitation, in Connecticutt. NANUC also offers academic and corporate service and scientific support through a newly created Technical Services Group.
NANUC is the home of the University of Alberta's metabolomics initiatives, having hosted various independent research initiatives, a portion of the Human Metabolome Project and the Magnetic Resonance Diagnostics Group (now Centre). NANUC is also the chosen service supplier for 800, 600 and 500 MHz NMR support to Chenomx. For more information, see www.nanuc.ca. | | |
 Founded in 2002, Biocrates is dedicated to further developing and harnessing a relatively young technology referred to as metabolomics.
The company’s research and development focus rests on two pillars:
One is the identification and validation of powerful biomarker panels that help identify disease risk, diagnose diseases, assess disease severity, and guide treatment. Biocrates has developed a comprehensive biomarker pipeline, covering indications from chronic disorders, such as type II diabetes, to acute events, such as stroke.
The other is to support other research organizations in developing biomarker panels that help assess how a new drug works in the body and identify patients most likely to respond to a treatment or least likely to suffer side effects. Such biomarkers, which are becoming part-and-parcel of the design of targeted therapies, are referred to as companion diagnostics.
This innovative, fully integrated technology platform for metabolomics is based on mass spectrometry, enabling the systematic quantification of a wide range of biologically relevant molecule classes in a wide range of samples, from blood and serum to cells or tissues.
For more information, see www.biocrates.com | | |
 Infocom Corporation, headquartered in Tokyo, was founded in 1983. Infocom is a comprehensive service IT company carrying out a wide range of business centered on the areas of medical services. In the field of biosciences, they have a strong emphasis on providing support for drug discovery researchers. They offer a variety of solutions including solutions to CCS, ADMET, data mining, statistical analysis, proteome and genome analysis. For more information, see www.infocom.co.jp/bio or contact info-science@infocom.co.jp. | | |
 Varian Inc., now part of Agilent Technologies, excels in creating high performance products, often combining diverse technologies and capabilities, to create new ways to meet the evolving needs of our customers. Varian Inc. instruments, consumable supplies, and solutions are key tools in bio-molecular and academic research, pharmaceutical R&D and manufacturing, and industrial R&D and quality control, and in developing everything from disease-resistant crops to cosmetics to testing drinking water and monitoring quality in the petrochemical industry. For more information, see www.varianinc.com. | | |
 Umetrics develops software for design of experiments and multivariate data analysis, for the individual user as well as for on-line continuous and batch processes. We provide training at more than 25 locations worldwide and on-site consulting services. We are committed to supporting our clients in their mission to take control over their data flow, by conveying our advanced expertise in multivariate technology.
The strengths that distinguish Umetrics in the market are our:
- State-of-the-art and user-friendly software that is a result of the close collaboration between advanced research in the field of multivariate methods and the software development
- Deep and extensive understanding of industry-specific applications of multivariate technology
- Transformation of expert material in statistics and mathematics into application-focused training courses
- Broad experience in consulting
For more information, see www.umetrics.com. | | |
 The Human Metabolome Project (HMP) is a $7.5 million Genome Canada funded project launched in January 2005. The purpose of the project is to facilitate metabolomics research through several objectives to improve disease identification, prognosis and monitoring; provide insight into drug metabolism and toxicology; provide a linkage between the human metabolome and the human genome; and to develop software tools for metabolomics. The project mandate is to identify, quantify, catalogue and store all metabolites that can potentially be found in human tissues and biofluids at concentrations greater than one micromolar. This data is freely accessible in an electronic format to all researchers through the Human Metabolome Database (www.hmdb.ca). In addition, all compounds are publicly available through the Human Metabolome Library (www.metabolibrary.ca). DrugBank (drugbank.ca) with its 3+ million hits and FooDB (hmdb.med.ualberta.ca/foodb) round out the HMP's collection of database resources. | | |
|
|
